This study analyzed sexual health in women with cervical cancer after being treated with chemoradiation or brachytherapy (a type of internal radiation). The researchers used questionnaires about sexual function and distress, and recorded how much radiation different parts of the vagina received. Roughly 73% of patients reported sexual dysfunction, and 55% reported significant sexual distress. They found that using higher doses of radiation to specific areas of the vagina, especially the rectovaginal area, caused worse sexual distress. Not only does the type of radiation treatment matter, but how radiation is distributed (dosimetry) may influence long-term side effects. Sexual health is an important and underrecognized outcome in cervical cancer treatment, and better attention to radiation dosing can improve quality of life.
Research article
Dosimetric Predictors of Sexual Toxicity in Cervical Cancer Patients Treated With Definitive Chemoradiation and MRI-Guided Brachytherapy
References
- Gulstene S, Chuk E, Conway J. Dosimetric predictors of sexual toxicity in cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy. Int J Radiat Oncol. 2026. doi:10.1016/j.ijrobp.2026.03.021.
Citation
. Dosimetric Predictors of Sexual Toxicity in Cervical Cancer Patients Treated With Definitive Chemoradiation and MRI-Guided Brachytherapy. ARO Student Scan. 2026;3(2). doi:10.37549/HotTopics_1_Q2_2026.
©Anderson Publishing, Ltd. All rights reserved. Reproduction in whole or part without express written permission is strictly prohibited.
More from Vol. 3, Issue 2
Research article
Career Development Opportunities in Radiation Oncology
Colin McNamara
June 2026 · Vol. 3, Issue 2
Research article
An Interview With Anupam Rishi, MD, Moffitt Cancer Center
Lillian Zhang
June 2026 · Vol. 3, Issue 2
Research article
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study
Anthony Alanis
June 2026 · Vol. 3, Issue 2
Research article
Efficacy and Safety of Diffusing Alpha-Emitter Radiation Therapy (DaRT) for Head and Neck Cancer Recurrence After Radiotherapy
Demetrius Moncrease
June 2026 · Vol. 3, Issue 2